The Journal of Nutritional Biochemistry
Volume 21, Issue 4 , Pages 297-303 , April 2010

Dietary zinc reduces osteoclast resorption activities and increases markers of osteoblast differentiation, matrix maturation, and mineralization in the long bones of growing rats

  • Kevin B. Hadley

      Affiliations

    • KBH is now located at the Martek Biosciences Corporation, Columbia, MD.
    • ,
  • Samuel M. Newman
    • ,
  • Janet R. Hunt

      Affiliations

    • Corresponding Author InformationCorresponding author.
    • JRH is now located at the International Atomic Energy Agency, Vienna, Austria.

Received 24 September 2008 ,Revised 24 December 2008 ,Accepted 5 January 2009.

References 

  1. Follis RH, Day RG, McCollum EV. Histological studies of the tissues of rats fed a diet extremely low in zinc. J Nutr. 1941;22:223–237
  2. O'Dell BL, Newberne PM, Savage JE. Significance of dietary zinc for the growing chicken. J Nutr. 1958;65:503–518
  3. Rossi L, Migliaccio S, Corsi A, Marzia M, Bianco P, Teti A, et al. Reduced growth and skeletal changes in zinc-deficient growing rats are due to impaired growth plate activity and inanition. J Nutr. 2001;131:1142–1146
  4. Zhang Y, Cheng Y, Hong Y, Li S. Zinc deficiency on pathological changes of femur epiphyseal growth plate in rats. Wei Sheng Yan Jiu. 2003;32:16–19
  5. da Cunha Ferreira RM, Rodriguez Gonzalez JI, Monreal Marquiegui I, Villa Elizaga I. Changes in the fetal tibial growth plate secondary to maternal zinc deficiency in the rat: a histological and histochemical study. Teratology. 1991;44:441–451
  6. Suwarnasarn A, Wallwork JC, Lykken GI, Low FN, Sandstead HH. Epiphyseal plate development in the zinc-deficient rat. J Nutr. 1982;112:1320–1328
  7. Eberle J, Schmidmayer S, Erben RG, Stangassinger M, Roth HP. Skeletal effects of zinc deficiency in growing rats. J Trace Elem Med Biol. 1999;13:21–26
  8. Oner G, Bhaumick B, Bala RM. Effect of zinc deficiency on serum somatomedin levels and skeletal growth in young rats. Endocrinology. 1984;114:1860–1863
  9. Hunt JR, Johnson LK. Dietary protein, as egg albumen: effects on bone composition, zinc bioavailability and zinc requirements of rats, assessed by a modified broken-line model. J Nutr. 1992;122:161–169
  10. Ovesen J, Moller-Madsen B, Thomsen JS, Danscher G, Mosekilde L. The positive effects of zinc on skeletal strength in growing rats. Bone. 2001;29:565–570
  11. Becker WM, Hoekstra WG. Effect of vitamin D on 65Zn absorption, distribution and turnover in rats. J Nutr. 1966;90:301–309
  12. Hurley LS, Gowan J, Milhaud G. Calcium metabolism in manganese-deficient and zinc-deficient rats. Proc Soc Exp Biol Med. 1969;130:856–860
  13. Holloway WR, Collier FM, Herbst RE, Hodge JM, Nicholson GC. Osteoblast-mediated effects of zinc on isolated rat osteoclasts: inhibition of bone resorption and enhancement of osteoclast number. Bone. 1996;19:137–142
  14. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev. 1993;73:79–118
  15. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem. 1989;264:17213–17221
  16. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem. 1988;263:6579–6587
  17. Pocker Y, Sarkanen S. Carbonic anhydrase: structure catalytic versatility, and inhibition. Adv Enzymol Relat Areas Mol Biol. 1978;47:149–274
  18. Susi FR, Goldhaber P, Jennings JM. Histochemical and biochemical study of acid phosphatase in resorbing bone in culture. Am J Physiol. 1966;211:959–962
  19. Miller SC. The rapid appearance of acid phosphatase activity at the developing ruffled border of parathyroid hormone activated medullary bone osteoclasts. Calcif Tissue Int. 1985;37:526–529
  20. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int. 1982;34:285–290
  21. Reeves PG. AIN-93 purified diets for the study of trace element metabolism in rodents. In:  Watson RR editors. Trace Elements in Laboratory Rodents. Boca Raton, FL: CRC Press, Inc.; 1996;p. 3–37
  22. Eeckhout Y, Delaisse JM, Vaes G. Direct extraction and assay of bone tissue collagenase and its relation to parathyroid-hormone-induced bone resorption. Biochem J. 1986;239:793–796
  23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254
  24. Lau KH, Onishi T, Wergedal JE, Singer FR, Baylink DJ. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin Chem. 1987;33:458–462
  25. Bessey OA, Lowry OH, Brock MJ. A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. J Biol Chem. 1946;164:321–329
  26. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al. Current protocols in molecular biology. New York, NY: John Wiley & Sons; 1995;
  27. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45
  28. Oda N, Sogawa CA, Sogawa N, Onodera K, Furuta H, Yamamoto T. Metallothionein expression and localization in rat bone tissue after cadmium injection. Toxicol Lett. 2001;123:143–150
  29. Hyun TH, Barrett-Connor E, Milne DB. Zinc intakes and plasma concentrations in men with osteoporosis: the Rancho Bernardo Study. Am J Clin Nutr. 2004;80:715–721
  30. Elmstahl S, Gullberg B, Janzon L, Johnell O, Elmstahl B. Increased incidence of fractures in middle-aged and elderly men with low intakes of phosphorus and zinc. Osteoporos Int. 1998;8:333–340
  31. Freudenheim JL, Johnson NE, Smith EL. Relationships between usual nutrient intake and bone-mineral content of women 35–65 years of age: longitudinal and cross-sectional analysis. Am J Clin Nutr. 1986;44:863–876
  32. Strause L, Saltman P, Smith KT, Bracker M, Andon MB. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994;124:1060–1064
  33. Saltman PD, Strause LG. The role of trace minerals in osteoporosis. J Am Coll Nutr. 1993;12:384–389
  34. Herzberg M, Lusky A, Blonder J, Frenkel Y. The effect of estrogen replacement therapy on zinc in serum and urine. Obstet Gynecol. 1996;87:1035–1040
  35. Herzberg M, Foldes J, Steinberg R, Menczel J. Zinc excretion in osteoporotic women. J Bone Miner Res. 1990;5:251–257
  36. Relea P, Revilla M, Ripoll E, Arribas I, Villa LF, Rico H. Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing. 1995;24:303–307
  37. Roughead ZK, Lukaski HC. Inadequate copper intake reduces serum insulin-like growth factor-I and bone strength in growing rats fed graded amounts of copper and zinc. J Nutr. 2003;133:442–448
  38. Hosea HJ, Taylor CG, Wood T, Mollard R, Weiler HA. Zinc-deficient rats have more limited bone recovery during repletion than diet-restricted rats. Exp Biol Med (Maywood). 2004;229:303–311
  39. Pallauf J, Kirchgessner M. Zinkgehalte in knochen und ganzkorper wachsender ratten bei unterschiedlicher zinkversorgung. Z Tierphysiol, Tierernahrg u Futtermittelkde. 1972;30:193–202
  40. Momcilovic B, Reeves PG, Blake MJ. Idiorrhythmic dose-rate variability in dietary zinc intake generates a different response pattern of zinc metabolism than conventional dose-response feeding. Br J Nutr. 1997;78:173–191
  41. Essatara MB, Levine AS, Morley JE, McClain CJ. Zinc deficiency and anorexia in rats: normal feeding patterns and stress induced feeding. Physiol Behav. 1984;32:469–474
  42. Evans SA, Overton JM, Alshingiti A, Levenson CW. Regulation of metabolic rate and substrate utilization by zinc deficiency. Metabolism. 2004;53:727–732
  43. Kennedy KJ, Rains TM, Shay NF. Zinc deficiency changes preferred macronutrient intake in subpopulations of Sprague–Dawley outbred rats and reduces hepatic pyruvate kinase gene expression. J Nutr. 1998;128:43–49
  44. Moonga BS, Dempster DW. Zinc is a potent inhibitor of osteoclastic bone resorption in vitro. J Bone Miner Res. 1995;10:453–457
  45. Tezuka K, Nemoto K, Tezuka Y, Sato T, Ikeda Y, Kobori M, et al. Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem. 1994;269:15006–15009
  46. Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol. 1994;124:1091–1102
  47. Huang WH, Lau AT, Daniels LL, Fujii H, Seydel U, Wood DJ, et al. Detection of estrogen receptor alpha, carbonic anhydrase II and tartrate-resistant acid phosphatase mRNAs in putative mononuclear osteoclast precursor cells of neonatal rats by fluorescence in situ hybridization. J Mol Endocrinol. 1998;20:211–219
  48. Takeshita S, Kaji K, Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res. 2000;15:1477–1488
  49. Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, Wang KZ, et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J Biol Chem. 2004;279:26475–26480
  50. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/Type IV collagenase=gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest. 1995;72:311–322
  51. Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H, et al. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology. 1998;139:1338–1345
  52. Sly WS, Hewett-Emmett D, Whyte MP, Yu YS, Tashian RE. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci U S A. 1983;80:2752–2756
  53. Waite LC. Carbonic anhydrase inhibitors, parathyroid hormone and calcium metabolism. Endocrinology. 1972;91:1160–1165
  54. Gay CV, Mueller WJ. Carbonic anhydrase and osteoclasts: localization by labeled inhibitor autoradiography. Science. 1974;183:432–434
  55. Zaidi M, Moonga B, Moss DW, MacIntyre I. Inhibition of osteoclastic acid phosphatase abolishes bone resorption. Biochem Biophys Res Commun. 1989;159:68–71
  56. Roth DE, Venta PJ, Tashian RE, Sly WS. Molecular basis of human carbonic anhydrase II deficiency. Proc Natl Acad Sci U S A. 1992;89:1804–1808
  57. Lehenkari P, Hentunen TA, Laitala-Leinonen T, Tuukkanen J, Vaananen HK. Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+. Exp Cell Res. 1998;242:128–137
  58. Schlesinger PH, Mattsson JP, Blair HC. Osteoclastic acid transport: mechanism and implications for physiological and pharmacological regulation. Miner Electrolyte Metab. 1994;20:31–39
  59. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem. 1995;270:5872–5876
  60. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 1998;93:411–422
  61. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol. 2000;151:879–889
  62. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A. 2000;97:3884–3889
  63. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002;3:889–901
  64. Raisz LG, Kream BE. Regulation of bone formation. N Engl J Med. 1983;309:83–89
  65. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res. 1992;7:683–692
  66. Gehron-Robey P. Principles of Bone Biology. San Diego, CA: Academic Press; 1996;
  67. Byers PH. Brittle bones–fragile molecules: disorders of collagen gene structure and expression. Trends Genet. 1990;6:293–300
  68. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, et al. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol. 1990;143:420–430
  69. Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 1990;4:3111–3123
  70. Weinreb M, Shinar D, Rodan GA. Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res. 1990;5:831–842
  71. McCabe LR, Kockx M, Lian J, Stein J, Stein G. Selective expression of fos- and jun-related genes during osteoblast proliferation and differentiation. Exp Cell Res. 1995;218:255–262
  72. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, et al. Increased bone formation in osteocalcin-deficient mice. Nature. 1996;382:448–452
  73. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, et al. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res. 1999;14:2015–2026
  74. Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP, et al. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol. 2004;164:841–847
  75. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999;13:1025–1036
  76. Ducy P. Cbfa1: a molecular switch in osteoblast biology. Dev Dyn. 2000;219:461–471
  77. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755–764
  78. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997;89:765–771

☆ Funded by the US Department of Agriculture (USDA) Agricultural Research Service. Mention of a trademark or proprietary product does not constitute a guarantee or warranty of the product by the USDA and does not imply its approval to the exclusion of other products that may also be suitable.

PII: S0955-2863(09)00009-6

doi: 10.1016/j.jnutbio.2009.01.002

The Journal of Nutritional Biochemistry
Volume 21, Issue 4 , Pages 297-303 , April 2010

Article Tools

* Image Usage & Resolution